Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Kwon, Eun-Ji  [Clear All Filters]
2024
Kim J, Kwon E-J, Kim Y-J, Kim D, Shin Y-Z, Gil D, Kim J-H, Shin HDoo, Kim LHyo, Lee M-O, et al. Epigenetic repression of CHCHD2 enhances survival from single cell dissociation through attenuated Rho A kinase activity. Cell Mol Life Sci. 2024;81(1):38.
2023
Kim J, Kim S, Lee S-Y, Jo B-K, Oh J-Y, Kwon E-J, Kim K-T, Adpaikar AAshok, Kim E-J, Jung H-S, et al. Partial in vivo reprogramming enables injury-free intestinal regeneration via autonomous induction. Sci Adv. 2023;9(47):eadi8454.
Kim Y-J, Go Y-H, Jeong H-C, Kwon E-J, Kim S-M, Cheong HSub, Kim W, Shin HDoo, Lee H, Cha H-J. TPX2 prompts mitotic survival via the induction of BCL2L1 through YAP1 protein stabilization in human embryonic stem cells. Exp Mol Med. 2023.
2022
Kim S-M, Kwon E-J, Kim Y-J, Go Y-H, Oh J-Y, Park S, Do JTae, Kim K-T, Cha H-J. Dichotomous role of Shp2 for naïve and primed pluripotency maintenance in embryonic stem cells. Stem Cell Res Ther. 2022;13(1):329.
Park J-C, Kim J, Jang H-K, Lee S-Y, Kim K-T, Kwon E-J, Park S, Lee HSik, Choi H, Park S-Y, et al. Multiple isogenic GNE-myopathy modeling with mutation specific phenotypes from human pluripotent stem cells by base editors. Biomaterials. 2022;282:121419.
2020
Kwon O-S, Lee H, Kong H-J, Kwon E-J, Park JEun, Lee W, Kang S, Kim M, Kim W, Cha H-J. Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer. Oncogene. 2020.
Kwon O-S, Kwon E-J, Kong H-J, Choi J-Y, Kim Y-J, Lee E-W, Kim W, Lee H, Cha H-J. Systematic identification of a nuclear receptor-enriched predictive signature for erastin-induced ferroptosis. Redox Biol. 2020;37:101719.